An important component of the vaccines protecting people against SARS-CoV-2 virus and its variants are lipid nanoparticles, or LNPs. These circular particles carry therapeutic mRNA payloads, the snippets of genetic material that trigger our immune systems to defend against COVID-19.
Molecular detection platform provides new insights into gene medicine manufacturing
- 23. 9 2022 (18:47)